Trillium Therapeutics Inc. T.TRIL

Healthcare Biotechnology

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.

TSX:TRIL - Post by User

Trillium Therapeutics Inc.

Bullboard Posts

Comment by Iceman2016on Feb 22, 2017 12:46pm

102 Views

Post# 25877944

RE:RE:insider buying

Indeed you are right but it sure gets the heartbeat going until you figure it out .
I have sent an e-mail to the 2 posters of this article to advise them of their mistake .

Please pull or fix your article you are referencing the incorrect company of Gordon Edward Zelko and affecting the share price of Trillium Therapeutics !

Sunvest Minerals Corp

Gordon Zelko

PRESIDENT & DIRECTOR

Gordon Zelko graduated with a major in economics from Simon Fraser University and has over 25 years of experience in the mining, energy and technology sectors, focusing on raising capital and building numerous strategic relationships. He has extensive knowledge of the capital markets and financing activities. Mr. Zelko has also developed expertise in the areas of business and strategic planning, leadership, identification of potential acquisitions, business development, and contract negotiations.

EvelKnievel wrote: This is misinformation, an auto genertated glitch of some sort. My DD shows me this insider info is for Sunvest Minerals Corp.

Make sure to do your DD thoroughly.